Immatics NV (IMTX)

[FACT-MASTER]

Thanks for pointing that out! That sounds very promising.

Given TCRX's success with targetting prame with leukemia, this does sound exceptionally promising.

TCRX has data showing durable activity with complete donor chimerism (they have used the word "cure" in some of their presentations)

Have a look here: ( slide 13/14 of particular interest)

https://ir.tscan.com/static-files/1d066354-1ed3-4f4f-b97b-28806d9da9f5

This data provides a good indicator, imo for IMTX"s upcoming presentation that you referenced.

Doing well, however busy with my work.